
212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
The Readout Loud
00:00
The Standing Ovation at Ascot Breast Cancer Conference
A breast cancer study done by die can ko and astrasentica for their drug conjugate elicited a standing ovation from the gathered crowd. It showed really a profound reduction in, not only in tumer progression, but also, you know, most importantly, a nice of, very substantial increase in survival. The last time that i was at asco where there was a standing o applause was in two thousand five for the rosh janntak breast cancer drug, her ceptin,.
Transcript
Play full episode